Project to Investigate Ways to Reduce the Spread of Influenza in Schools and Households With Children

NCT ID: NCT00446628

Last Updated: 2016-01-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

3360 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-01-31

Study Completion Date

2009-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to understand the spread of influenza (flu) in schools and households with elementary (K-5) school children, and develop ways to reduce the flu using non-pharmaceutical means.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Pandemic influenza threatens to cause substantial disability, death, and societal disruption and to overwhelm health care systems in the United States and around the world. Because effective vaccines may not be available during the initial months of a pandemic, and because anti-viral medication is both largely ineffective and in short supply, non-pharmacological personal protection and behavioral changes may be the only means to combat the epidemic. In our computational modeling work (through the Models of Infectious Disease Agent Study network), we have shown the potential value of multiple targeted and layered non-pharmacological interventions in blunting the peak impact and slowing of a pandemic (Nature, in press).

Phase 1 of the project will be a pilot study in two elementary schools in the City of Pittsburgh. The project has already obtained agreement to collaborate from the Pittsburgh Public School System and we have assembled a multi-disciplinary team of epidemiologists, systems analysts, modelers, community and minority health workers, and virologists to implement the project. Phase one was in 2 schools.

Phase 2 will be similar to Phase 1 with the addition of additional schools and application of a "hygiene" intervention to selected schools and families. Phase 2 is in 10 schools with 3800 students.

Specific aims (year 02):

Primary

1. Measure the effectiveness of non-pharmaceutical interventions (NPIs) in reducing influenza rates among enrolled students in the intervention and control schools when influenza is known to be circulating in the community. \[Note: Enrolled, for purposes of PIPP, will indicate students who present with ILI, consent to participate, and are tested for influenza during the flu season.\] Secondary: School-Based
2. Measure number of absentees and determine the reason for absence by using a school based absentee illness surveillance system prior to and through the end of influenza season.
3. Measure the effectiveness of NPIs in reducing absenteeism from all causes, including illness/URI, illness/ILI, illness/other, and illness/GI through the end of influenza season.
4. Measure the effectiveness of NPIs in reducing secondary spread of ILI within classrooms of participating schools.
5. Assess adoption of NPI behaviors and activities in classrooms of intervention schools.

Secondary: Home-Based
6. Measure the effectiveness of NPIs in reducing secondary cases of ILI within families of enrolled school children with influenza.
7. Assess adherence of families of enrolled school children with influenza to isolation-related NPI behaviors and activities.

Tertiary
8. Measure correlation between rapid flu testing and PCR testing for influenza.
9. Collect and archive influenza specimens for future molecular epidemiological studies.
10. Contribute a sample of influenza-positive specimens to the CDC for national influenza surveillance purposes.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Influenza

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

intervention

Five elementary school received intervention consistin of training in hand and respiratory hygiene, and access to hand sanitizer

Group Type EXPERIMENTAL

behaviors reducing spread of influenza

Intervention Type BEHAVIORAL

Non-pharmaceutical interventions for flu prevention

control

Five elementary school received no training or hand sanitizer.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

behaviors reducing spread of influenza

Non-pharmaceutical interventions for flu prevention

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Students in grades K-8 with a current influenza-like illness (ILI) during flu season.ILI defined as an oral or aural temperature \> 100 °F AND either new onset cough or sore throat.Flu season is defined as December, 2006 through March/April, 2007.
* Parental consent and student assent.


* Shares living space with K-8 child who has current influenza infection.
* Parental consent and child assent in the case of minors.
* Individual consent if over the age of 18.
* Will continue in the study even if student with confirmed influenza withdraws from the study.

Exclusion Criteria

* The participant has a medical or mental health condition which in the judgment of the investigator is a barrier to safe participation.
* The participant is unable to tolerate a swab or capillary finger stick.
* There is a delay in notification or testing such that symptoms have resolved.


* The participant has a medical or mental health condition which in the judgment of the investigator is a barrier to safe participation.
* The participant is younger than 6 months.
* The participant is unable to tolerate a swab or capillary finger stick.
Minimum Eligible Age

6 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kiren Mitruka

FED

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Kiren Mitruka

Medical officer

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Donald S Burke, MD

Role: PRINCIPAL_INVESTIGATOR

University of Pittsburgh

Sam Stebbins, MD, MPH

Role: PRINCIPAL_INVESTIGATOR

University of Pittsburgh School of Public Health

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Pittsburgh

Pittsburgh, Pennsylvania, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CDC-U01 CI000435-01

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

CDC-NCPDCID-CC-0612047

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.